Diabetes Asia Journal (DAJ), open access, peer-reviewed, Single blinded quarterly journal publishing since 2024 under JHRC Publisher, aims to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. DAJ is dedicated to transferring technology and research by publishing scientific journals and research content, providing professional membership, and conducting conferences, seminars, and award programs. With the aim of faster and better dissemination of knowledge, we will publish the article ‘Ahead of Print’ immediately upon acceptance. In addition, the journal would allow free (open access) access to its contents, which is likely to attract more readers and citations to articles published in DAJ.
The journal requires that authors follow the ICMJE (International Committee of Medical Journal Editors) recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. More information can be found here: http://www.icmje.org. The uniform requirements and specific requirements of DAJ are mentioned below. Before sending a manuscript, contributors are requested to check for the author guidelines, which are available on the website of the journal https://diabetesasia.org/journal/author-guidelines;manuscript submission website https://diabetesasia.org/journal/
Aims and Scope:
Diabetes Asia Journal under JHRC is an innovative, research, online, open-access, single-blind peer-reviewed Journal that accepts solicited and unsolicited manuscripts. Articles published in the Diabetes Asia Journal under JHRC are Superior-quality, clinical, and basic, influential research articles by established academic authors and new researchers. The paramount objective of the Journal is to encourage and promote distinguished research in diabetes, hypertension, maternal-fetal medicine, gestational diabetes, and NCDs health, as well as inspire and motivate all contributors to advance the field. The articles published in Diabetes Asia Journal under JHRC include Editorial, Correspondence, Opinion Review, Frontier, Review, Minireview, Clinical Research, Basic Study, Meta-analysis, Evidence-based Medicine, Clinical Guidelines, Letter to the Editor, and Case Report. The journal aims to serve society by publishing clinical and basic science research on Diabetes and Gestational Diabetes. The journal seeks to publish a research-oriented manuscript addressing significant issues in all the subjects and areas of Gestational Diabetes, PCOD, Pre-eclampsia, and intrauterine programming for adult NCDs. Journal has committed itself to improving Education and Research on Environmental Effects on Reproductive Health, Maternal-Fetal Medicine, Midwifery, Menopause, Prenatal Diagnosis, Perinatology, Reproduction, Reproductive Physiology, Sexual Health, and adolescent health.
Diabetes Asia Journal is published under JHRC and covers Diabetes Research, including NCDs, specifically in Central Asia, South Asia, Southeast Asia, and Asia Pacific.2. APC: Article processing charges are completely waived for 2 years from Jan 2024 to Jan 2026
All the articles are Open Access and are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third-party material in this article are included in the article’s Creative Commons license unless stated otherwise in a credit line to the material. Suppose the material is not included in the article’s Creative Commons license, and your intended use is prohibited by statutory regulation or exceeds the permitted use. In that case, you must obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
3. Without restrictions, the authors retain the copyright and full publishing rights for the article/documents/guidelines/published in Diabetes Asia Journal.
4. Diabetes Asia Journal routinely screens article submissions for plagiarism
through https://www.ithenticate.com/products/crossref-similarity-check and accepts less than 10% similar content.
5. Repository as a preprint can be deposited on the Journal website for which a DOI preprint will be given and available till the article is published.
6. Diabetes Asia Journal under JHRC is a signatory of the Declaration on Research Assessment (DORA), which emphasizes continued improvement in evaluating researchers and scholarly research outputs.
7. Diabetes Asia Journal under JHRC is a publisher and Member of Crossref withDOI: doi.org/10.62996/daj.10002024 and ISSN 3048-8192.
8. All the Published articles are archived at https://archive.org/details/@diabetes_asia/uploadshttps://sfdora.org/signers/?_signers_keyword=Diabetesasia&_organization_country=india
This is an open-access journal, meaning that all content is freely available to the user or his/her institution without charge. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is the definition of open access defined by the Budapest Open Access Initiative (BOAI).
https://sfdora.org/signers/?_signers_keyword=Diabetesasia&_organization_country=india
This is an open-access journal, meaning that all content is freely available to the user or his/her institution without charge. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is the definition of open access defined by the Budapest Open Access Initiative (BOAI).
